Project Details
Description
A multinational, multicenter, single blood sampling exploratory pharmacogenetic study of the REGARD (the REbif vs Glatiramer Acetate in Relapsing MS Disease) trial
| Status | Finished |
|---|---|
| Effective start/end date | 2/17/10 → 8/16/12 |
Funding
- EMD SERONO, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.